TELA Bio's market cap is currently $111.86M. The company's EPS TTM is $-1.687; its P/E ratio is ―; TELA Bio is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 58.45M	$ 41.42M	$ 29.46M	$ 18.21M	$ 15.45M
Gross Profit	$ 40.11M	$ 27.04M	$ 18.81M	$ 11.23M	$ 9.27M
Operating Income	$ -44.08M	$ -39.01M	$ -29.45M	$ -25.27M	$ -19.16M
EBITDA	$ -40.63M	$ -39.06M	$ -29.14M	$ -24.70M	$ -18.23M
Net Income	$ -46.66M	$ -44.34M	$ -36.11M	$ -31.88M	$ -25.80M
Balance Sheet
Cash & Short-Term Investments	$ 46.73M	$ 42.02M	$ 43.93M	$ 74.39M	$ 54.59M
Total Assets	$ 78.05M	$ 67.86M	$ 62.54M	$ 86.46M	$ 67.92M
Total Debt	$ 41.08M	$ 39.92M	$ 31.49M	$ 30.83M	$ 30.24M
Net Debt	$ -5.65M	$ -2.10M	$ -12.44M	$ -43.57M	$ -15.06M
Total Liabilities	$ 59.17M	$ 53.55M	$ 42.45M	$ 37.43M	$ 36.96M
Stockholders' Equity	$ 18.88M	$ 14.30M	$ 20.10M	$ 49.03M	$ 30.96M
Cash Flow
Free Cash Flow	$ -41.47M	$ -42.62M	$ -31.06M	$ -24.62M	$ -28.22M
Operating Cash Flow	$ -40.86M	$ -40.75M	$ -30.43M	$ -24.46M	$ -25.52M
Investing Cash Flow	$ -599.00K	$ -1.87M	$ -627.00K	$ 9.12M	$ -11.98M
Financing Cash Flow	$ 46.27M	$ 40.85M	$ 585.00K	$ 44.41M	$ 65.53M

Currency in USD

TELA Bio Earnings and Revenue History

Income Statement >

TELA Bio Debt to Assets

Balance Sheet >

TELA Bio Cash Flow

Cash Flow >

TELA Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing